Clinical trial

Evaluation With CT Scan of Possible Changes in Airways After Treatment With Daxas® in Severe Chronic Obstructive Pulmonary Disease Patients

NCT01480661

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Roflumilast Normalized identity: roflumilastView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo of Roflumilast Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Functional Respiratory Imaging Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Evaluation With CT Scan of Possible Changes in Airways After Treatment With Daxas® in Severe Chronic Obstructive Pulmonary Disease Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-12-01

PhasePHASE4

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

RoflumilastDRUG · verified · RxNorm: roflumilast

Placebo of RoflumilastDRUG

Functional Respiratory ImagingRADIATION

Sponsors & collaborators

FLUIDDA nvlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01480661 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.